Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-029859

Chief Business Officer sold 75,000 shares at $30.05 ($2,253,885)

  • Chief Business Officer acquired 75,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Parrish Jay · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-14 Exercise or conversion : show line 1 in the form +75,000 $1.49 $111,375 297,222 D
2020-05-14 Sale : show line 2 in the form −75,000 $30.05 $2,253,885 222,222 D
Open-market sales · 75,000 sh · avg $30.05 · $2,253,885

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-05-14 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −75,000 147,221 D
Loading xslF345X03/doc4.xml…